Header Logo

Connection

Johannes Elferich to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Johannes Elferich has written about Xenograft Model Antitumor Assays.
Johannes Elferich
Connection Strength
0.034
Xenograft Model Antitumor Assays
  1. Hosseini MM, Kurtz SE, Abdelhamed S, Mahmood S, Davare MA, Kaempf A, Elferich J, McDermott JE, Liu T, Payne SH, Shinde U, Rodland KD, Mori M, Druker BJ, Singer JW, Agarwal A. Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia. 2018 11; 32(11):2374-2387.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.